Terms: = Gastric cancer AND DDX3X, DDX14, 1654, ENSG00000215301, DBX, DDX3, HLP2
14 results:
1. N
Xu P; Liu K; Huang S; Lv J; Yan Z; Ge H; Cheng Q; Chen Z; Ji P; Qian Y; Li B; Xu H; Yang L; Xu Z; Zhang D
Gastric Cancer; 2024 Mar; 27(2):275-291. PubMed ID: 38252226
[TBL] [Abstract] [Full Text] [Related]
2. TM4SF1-AS1 inhibits apoptosis by promoting stress granule formation in cancer cells.
Kitajima H; Maruyama R; Niinuma T; Yamamoto E; Takasawa A; Takasawa K; Ishiguro K; Tsuyada A; Suzuki R; Sudo G; Kubo T; Mitsuhashi K; Idogawa M; Tange S; Toyota M; Yoshido A; Kumegawa K; Kai M; Yanagihara K; Tokino T; Osanai M; Nakase H; Suzuki H
Cell Death Dis; 2023 Jul; 14(7):424. PubMed ID: 37443145
[TBL] [Abstract] [Full Text] [Related]
3. Organ doses and cancer risk assessment in patients exposed to high doses from recurrent CT exams.
Zewde N; Ria F; Rehani MM
Eur J Radiol; 2022 Apr; 149():110224. PubMed ID: 35217250
[TBL] [Abstract] [Full Text] [Related]
4. Cytosponge-trefoil factor 3 versus usual care to identify Barrett's oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial.
Fitzgerald RC; di Pietro M; O'Donovan M; Maroni R; Muldrew B; Debiram-Beecham I; Gehrung M; Offman J; Tripathi M; Smith SG; Aigret B; Walter FM; Rubin G; ; Sasieni P
Lancet; 2020 Aug; 396(10247):333-344. PubMed ID: 32738955
[TBL] [Abstract] [Full Text] [Related]
5. Influence of sex on chemotherapy efficacy and toxicity in oesophagogastric cancer: A pooled analysis of four randomised trials.
Davidson M; Wagner AD; Kouvelakis K; Nanji H; Starling N; Chau I; Watkins D; Rao S; Peckitt C; Cunningham D
Eur J Cancer; 2019 Nov; 121():40-47. PubMed ID: 31542640
[TBL] [Abstract] [Full Text] [Related]
6. [Characteristics and risk factors of lymphatic metastasis in early gastric cancer].
Wang JM; Zhou LY; Lin SR; Ding SG
Zhonghua Nei Ke Za Zhi; 2010 Apr; 49(4):297-300. PubMed ID: 20627034
[TBL] [Abstract] [Full Text] [Related]
7. Phase II study of oxaliplatin, UFT, and leucovorin in patients with metastatic gastric cancer.
Siemerink EJ; Drenth AF; Mulder NH; Plukker JT; Hospers GA
Gastric Cancer; 2010 Jun; 13(2):95-100. PubMed ID: 20602196
[TBL] [Abstract] [Full Text] [Related]
8. Trends in incidence of esophageal and gastric cardia cancer in high-risk areas in China.
He YT; Hou J; Chen ZF; Qiao CY; Song GH; Meng FS; Jin HX; Chen C
Eur J Cancer Prev; 2008 Apr; 17(2):71-6. PubMed ID: 18287862
[TBL] [Abstract] [Full Text] [Related]
9. gastric cancer in young patients.
Eguchi T; Takahashi Y; Yamagata M; Kasahara M; Fujii M
J Am Coll Surg; 1999 Jan; 188(1):22-6. PubMed ID: 9915238
[TBL] [Abstract] [Full Text] [Related]
10. Relevant prognostic factors in gastric cancer: ten-year results of the German gastric cancer Study.
Siewert JR; Böttcher K; Stein HJ; Roder JD
Ann Surg; 1998 Oct; 228(4):449-61. PubMed ID: 9790335
[TBL] [Abstract] [Full Text] [Related]
11. [Value of radical lymph node dissection (compartment I and II) in stomach carcinoma].
Böttcher K; Roder JD; Siewert JR
Zentralbl Chir; 1996; 121(2):131-8. PubMed ID: 8868609
[TBL] [Abstract] [Full Text] [Related]
12. Prognostic factors in gastric carcinoma. Results of the German gastric Carcinoma Study 1992.
Roder JD; Böttcher K; Siewert JR; Busch R; Hermanek P; Meyer HJ
Cancer; 1993 Oct; 72(7):2089-97. PubMed ID: 8374867
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic relevance of systematic lymph node dissection in gastric carcinoma. German gastric Carcinoma Study Group.
Siewert JR; Böttcher K; Roder JD; Busch R; Hermanek P; Meyer HJ
Br J Surg; 1993 Aug; 80(8):1015-8. PubMed ID: 8402053
[TBL] [Abstract] [Full Text] [Related]
14. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y
Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144
[TBL] [Abstract] [Full Text] [Related]
